Related Experiment Video
Updated: Feb 4, 2026

Motor Dual-Tasks for Gait Analysis and Evaluation in Post-Stroke Patients
Published on: March 11, 2021
Chart review across EU5 in MM post-ASCT patients
John Ashcroft1,1, Davneet Judge2,2, Sujith Dhanasiri3,3
1Department of Haematology, Mid-Yorkshire NHS Trust, Wakefield, WF1 4DG2, UK.
Aim:
To understand the current treatment patterns, clinical outcomes and healthcare resource utilization-associated costs for multiple myeloma patients, post autologous stem cell transplant (ASCT) across Europe.
Patients & Methods:
Medical records were used to abstract data for 337 multiple myeloma patients who had received ASCT.
Results:
Following ASCT, 7% received maintenance therapy prior to progression. Lenalidomide was the most frequently prescribed maintenance, second- and third-line therapy. Monthly resource use was considerably lower in patients who received maintenance therapy (€638.14 vs €1001.74). Median time to progression was longer for patients who had received maintenance therapy.
Conclusion:
The study highlights the diversity in current treatment patterns post-ASCT. Results suggest patients who receive maintenance therapy have a prolonged remission period, and as a result their associated healthcare resource utilization is spread across the treatment pathway.
More Related Videos
Related Concept Videos
Run Charts
The R Chart
R charts are pivotal for pinpointing shifts in process variability. Stability is indicated when all data points remain within the defined upper and lower...
Pareto Chart
The Pareto chart is named after the Italian economist Vilfredo Pareto, who described the Pareto...
Interpreting R Charts
An R chart plots the range of subsets of measurements collected from a process. Each point on the chart represents the range—defined as the difference between the maximum and minimum...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview

